at all, the risk
that Soliris will not generate interest among physicians, the risk that
estimates regarding the number of PNH patients are inaccurate, the risk
that pending litigation may be resolved adversely, and a variety of other
risks set forth from time to time in Alexion's filings with the Securities
and Exchange Commission, including but not limited to the risks discussed
in Alexion's Quarterly Report on Form 10-Q for the period ended June 30,
2007 and in our other filings with the Securities and Exchange Commission.
Alexion does not intend to update any of these forward-looking statements
to reflect events or circumstances after the date hereof, except when a
duty arises under law.
(1) Rother R, Bell L, Hillmen P, Gladwin M. The clinical sequelae of
intravascular hemolysis and extracellular plasma hemoglobin. JAMA
2005; 293:1653-1662.
(2) Parker C, Omine M, Richards S, et al. Diagnosis and management of
paroxysmal nocturnal hemoglobinuria. Blood 2005; 106:3699-3709.
(3) Socie G, Mary J Yves, de Gramont A, et al. Paroxysmal nocturnal
haemoglobinuria: long-term follow-up and prognostic factors. Lancet
1996; 348:573-577.
(4) Hillmen P. Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history
of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;
333:1253-1258.
(5) Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of
paroxysmal nocturnal haemoglobinuria using modern diagnostic assays.
Br J Haematol. 2004;126:133-138.
(6) Araten DJ, Thaler HT, Luzzatto L. High incidence of thrombosis in
African-American and Latin-American patients with Paroxysmal
Nocturnal Haemoglobinuria. Thromb Haemost. 2005;93:88-91.
(7) Nishimura J, Kanakura Y, Ware RE et al. Clinical course and flow
cytometric analysis of paroxysmal nocturnal hemoglobinuria in the
United States and J
'/>"/>
SOURCE Alexion Pharmaceuticals, Inc.
 Copyright©2007 PR Newswire. | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
Sensitive detection of tumor cells in
peripheral blood of carcinoma patients
by a reverse transcription PCR method2.
Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A3.
What patients want: A story of choice, clinical trials & evidence-based medicine4.
Heart patients benefit from digital image network5.
LEDS Bring Relief to Young Cancer Patients6.
CPM Helps Physicians Group Retain Patients with New Kind of House Call7.
Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood8.
Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood
Mini Kit9.
Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood
Mini Kit10.
EppendorfPerfect gDNA Blood Mini Kit11.
Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit
by Varying the Final Elution Volume